Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1Ser616 Phosphorylation-Mediated Mitochondrial Fission
- PMID: 33041784
- PMCID: PMC7528720
- DOI: 10.3389/fphar.2020.01083
Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1Ser616 Phosphorylation-Mediated Mitochondrial Fission
Abstract
Our previous studies showed that Astragaloside IV derivative (LS-102) exhibited potent protective function against ischemia reperfusion (I/R) injury, but little is known about the mechanisms. Mitochondrial fission regulated by dynamin-related protein1 (Drp1) is a newly recognized determinant of mitochondrial function. This study aimed to investigate the protection of LS-102 on mitochondrial structure and function by regulating the activity of Drp1 using models of H9c2 cardiomyocyte injury induced by hypoxia-reperfusion (H/R), and rat heart injury induced by I/R. The results showed that LS-102 significantly decreased apoptosis, levels of ROS, CK, LDH, and calcium, upregulating MMP, and the Bax/Bcl-2 ratio in cardiomyocytes during I/R injury. Furthermore, LS-102 prevented I/R-induced mitochondrial fission by decreasing Drp1's mitochondrial localization through decreasing the phosphorylation of Drp1 at Ser616 (Drp1Ser616) and increasing the phosphorylation of Drp1 at Ser637 (Drp1Ser637) in H9c2 cells. Importantly, we also robustly confirmed Drp1Ser616 as a novel GSK-3β phosphorylation site. GSK-3β-mediated phosphorylation at Drp1Ser616 may be associated with mitochondrial fission during I/R of cardiomyocytes. In conclusion, LS-102 exerts cardio protection against I/R-induced injury by inhibiting mitochondrial fission via blocking GSK-3β-mediated phosphorylation at Ser616 of Drp1.
Keywords: Drp1 phosphorylation; GSK-3β; astragalosidic acid; mitochondrial fission; myocardial ischemia reperfusion.
Copyright © 2020 Chen, Chen, Wang, Yang, Zhou, Ding, Qing and Luo.
Figures
Similar articles
-
Crocetin protects cardiomyocytes against hypoxia/reoxygenation injury by attenuating Drp1-mediated mitochondrial fission via PGC-1α.J Geriatr Cardiol. 2023 Jan 28;20(1):68-82. doi: 10.26599/1671-5411.2023.01.001. J Geriatr Cardiol. 2023. PMID: 36875162 Free PMC article.
-
PTEN-induced kinase 1-induced dynamin-related protein 1 Ser637 phosphorylation reduces mitochondrial fission and protects against intestinal ischemia reperfusion injury.World J Gastroenterol. 2020 Apr 21;26(15):1758-1774. doi: 10.3748/wjg.v26.i15.1758. World J Gastroenterol. 2020. PMID: 32351292 Free PMC article.
-
lncRNA Oip5-as1 inhibits excessive mitochondrial fission in myocardial ischemia/reperfusion injury by modulating DRP1 phosphorylation.Cell Mol Biol Lett. 2024 May 14;29(1):72. doi: 10.1186/s11658-024-00588-4. Cell Mol Biol Lett. 2024. PMID: 38745296 Free PMC article.
-
Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2+-Calcineurin-Mediated Drp1 Signaling Pathways.Int J Mol Sci. 2017 Aug 25;18(9):1825. doi: 10.3390/ijms18091825. Int J Mol Sci. 2017. PMID: 28841143 Free PMC article.
-
The role of Drp1 adaptor proteins MiD49 and MiD51 in mitochondrial fission: implications for human disease.Clin Sci (Lond). 2016 Nov 1;130(21):1861-74. doi: 10.1042/CS20160030. Clin Sci (Lond). 2016. PMID: 27660309 Review.
Cited by
-
Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications.Cell Biol Toxicol. 2023 Feb;39(1):33-51. doi: 10.1007/s10565-022-09716-2. Epub 2022 Aug 11. Cell Biol Toxicol. 2023. PMID: 35951200 Review.
-
Anemoside B4 alleviates arthritis pain via suppressing ferroptosis-mediated inflammation.J Cell Mol Med. 2024 Feb;28(4):e18136. doi: 10.1111/jcmm.18136. J Cell Mol Med. 2024. PMID: 38334255 Free PMC article.
-
Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy.J Transl Med. 2022 Oct 4;20(1):447. doi: 10.1186/s12967-022-03642-x. J Transl Med. 2022. PMID: 36192726 Free PMC article.
-
Targeting mitochondrial shape: at the heart of cardioprotection.Basic Res Cardiol. 2023 Nov 13;118(1):49. doi: 10.1007/s00395-023-01019-9. Basic Res Cardiol. 2023. PMID: 37955687 Free PMC article.
-
Kinase signalling adaptation supports dysfunctional mitochondria in disease.Front Mol Biosci. 2024 Jan 26;11:1354682. doi: 10.3389/fmolb.2024.1354682. eCollection 2024. Front Mol Biosci. 2024. PMID: 38434478 Free PMC article. Review.
References
-
- Chinese Pharmacopoeia Commission. (2015). Chinese Pharmacopoeia (2015 Ed.). Beijing: China Medical Science Press, 302–303.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous